Stockholders' Deficit (Details Textual) - USD ($)		3 Months Ended		12 Months Ended
	Jun. 30, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Stockholders' Deficit (Textual)
Preferred stock, par value		$ 0.00001		$ 0.00001
Preferred stock, authorized		15,000,000		15,000,000
Designated shares		4,471,489
Common stock authorized		50,000,000		50,000,000
Common stock par value		$ 0.00001		$ 0.00001
Non-vested granted forfeitable shares
Shares of restricted common stock		10,000
Warrants, exercisable		$ 274,224
Stock-based compensation expense weighted average period term		2 years 1 month 6 days
Number of shares, Granted		975,000	0
Stock-based compensation expense for stock options		$ 219,170	$ 48,917
Stock-based compensation		$ 27,500
Stock-based compensation expenses, description		Stock-based compensation related to restricted shares and restricted stock units was of $34,511 and $161,458 during the three months ended March 31, 2019 and 2018, respectively. Unrecognized compensation expense related to the unvested restricted stock units described above is approximately $532,000 as of March 31, 2019 and is expected to be recognized over approximately 2.9 years. During the three months ended March 31, 2019, 1,200 restricted stock units were forfeited.
Warrant shares		274,224
Stock option, description		The 2019 granted options had an exercise prices ranging from $3.20, expire in ten years, and vest over four years. The total grant date fair value of these options was approximately $1,762,180 for the three months ended March 31, 2019, respectively.		The 2018 Plan provides for the grant of equity awards to purchase shares of common stock. Up to 3,000,000 shares of common stock may be issued pursuant to awards granted under the 2018 Plan, subject to increases that occur starting in 2021. The 2018 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board.
Acquisition of stock, description		The 2016 Plan provides for the grant of equity awards to highly qualified personnel, including stock options, restricted stock, stock appreciation rights, and restricted stock units to purchase shares of common stock. Up to 2,227,777 shares of common stock may be issued pursuant to awards granted under the 2016 Plan.
Total proceeds from the exercise of warrants		$ 873,403
Forfeitable restricted stock shares		400,000
Employees [Member]
Stockholders' Deficit (Textual)
Number of shares, Granted		140,000
Issuance of common stock		169,243
Warrants exercised		461,294
Initial Public Offering [Member]
Stockholders' Deficit (Textual)
Series Seed 1 shares issued	2,429,638
Preferred stock converted into common stock	$ 2,429,638